• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Page 5 > News & stories

Viewpoints

Page 5 > News & stories

Viewpoints

filters

Type & Disease
Topic
Location
Date Range
Type & Disease

By Type

news type

By Disease

diseases

Topic

By Topic

topic type

Location

By Location

location-news

Date Range

By Year

date range filter – slider
1999 — 2026

Results

No results found. Please try using different filter option(s).

Press releases
27 Apr 2026

Thailand registers ravidasvir, a simple-to-use and effective antiviral for hepatitis C, expanding treatment options for Thai patients

Times of India logo
In the media
24 Apr 2026

Dengue treatments in 2-3 years, but cases set to rise with climate change

Times of India
The New Indian Express logo
In the media
23 Apr 2026

India eyes dengue treatment rollout within five years as vaccine pipeline advances

The New Indian Express
El Mundo logo
In the media
26 Mar 2026

Un golpe de efecto para acabar con la enfermedad del sueño: “Aspiramos a eliminar el trastorno en 2030”

El Mundo
RNE logo
In the media
2 Apr 2026

La milagrosa cura de la enfermedad del sueño

RTVE
Stories

Lab lessons that matter: Pharmacy students help bridge the gap in research for neglected diseases

Stories
16 Apr 2026

One dose, one cure

Scientific articles
14 Apr 2026

Translational Pharmacokinetic-Pharmacodynamic Modeling and Efficacious Human Dose Prediction of DNDI-6148 for the Treatment of Cutaneous Leishmaniasis

Clinical and Translational Science
Le Monde logo
In the media
11 Apr 2026

Face à la dengue, la recherche s’active alors que le réchauffement laisse craindre une saison 2026 record

Le Monde
Scientific articles
27 Mar 2026

Prognostic models predicting clinical outcomes in patients diagnosed with visceral leishmaniasis: a systematic review

BMJ Public Health
News
31 Mar 2026

DNDi is looking for a Board Treasurer to join its Board of Directors

Chemistry World logo, C and W letters in a light grey on a black background
In the media
26 Mar 2026

Boron plays a key role in new sleeping sickness drug

Chemistry World
Title copy on white and orange background, picture of Fr Robinson on the right hand
Videos
26 Mar 2026

Manufacturing medicines for NTDs, with Dr Stephen Robinson

Scientific articles
14 Jan 2026

(Un)intended consequences: a social sciences stocktake of a decade of Global Action Plan-inspired antimicrobial governance

The Lancet Microbe
Scientific articles
24 Mar 2026

The burden of eumycetoma in Africa: a neglected fungal disease

The Lancet Regional Health – Africa
Statements
23 Mar 2026

DNDi statement at the sixth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement

loading
Loading...
Protesters call for affordable access to hepatitis C medicines outside of international congress
Viewpoints
12 Oct 2020

It takes more than good science to defeat a disease. Just look at the Nobel Prize.

Barron's
Viewpoints Translations
1 Aug 2020

Recherche et covid-19 : cinq mesures concrètes à adopter par les gouvernements

Prescrire
Viewpoints
4 May 2020

New health tools for COVID-19

Euractiv
Scientist holding a test tube
Viewpoints
3 Apr 2020

How best to prevent and treat COVID-19 in resource-limited settings?

Viewpoints
26 Jan 2018

How has drug discovery at DNDi evolved over the past decade?

Bernard Pecoul NTD summit
Viewpoints
24 May 2017

NTD Summit 2017: this is not (yet) the endgame

Viewpoints
15 Feb 2017

“We need to ensure that results of R&D are affordable and available to patients”

Gonorrhea Bacteria
Viewpoints
30 Jun 2016

The global response to AMR must not fail to address the needs of neglected patients

Viewpoints
28 Apr 2016

What role for DNDi in hepatitis C?

Carolina Batista examines a Chagas patient.
Viewpoints
23 Feb 2016

Chagas disease: Bridging the gap between patients and treatment

Viewpoints
28 Nov 2015

Breakthrough treatments for the most neglected diseases: diversifying approaches is required to expand the development pipeline with new chemical entities

Viewpoints
26 Jun 2015

The FACT project: a successful approach to solving public health needs

Viewpoints
30 Apr 2015

Chagas Disease in Colombia: An opportunity to lead the way towards change

Viewpoints
26 Feb 2015

Will Crisis See a Long-Awaited Response to Lack of Innovation and Access Come from Public Leadership?

Viewpoints
25 Nov 2014

Strengthening the Malaria Treatment Arsenal for Children in Africa

Viewpoints
29 Sep 2014

Learning to deliver: Challenges in NTD drug research and development

1 2 … 6 ›

Connect and share

Follow us on social media to stay updated and help us share the stories of neglected patients.  

Linkedin Instagram X-twitter Facebook Youtube
EM PORTUGUÊS
EN ESPAÑOL
Linkedin-in Instagram Youtube X-twitter Tiktok Facebook-f
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license